Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 26 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

23%

6 trials in Phase 3/4

Results Transparency

6%

1 of 16 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
12(66.7%)
Phase 3
3(16.7%)
Phase 4
3(16.7%)
18Total
N/A(12)
Phase 3(3)
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT07369700Not ApplicableEnrolling By Invitation

Evaluation of an mHealth-CHW Tool for Post-c-section Follow-up in Rural Rwanda

Role: collaborator

NCT06812208Not ApplicableNot Yet Recruiting

Strategies to Decentralize Breast Ultrasound in Rwanda

Role: collaborator

NCT03896685Phase 3Completed

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Role: collaborator

NCT02754765Phase 3Completed

Evaluating Newly Approved Drugs for Multidrug-resistant TB

Role: collaborator

NCT05364138Completed

Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda

Role: collaborator

NCT05871489Active Not Recruiting

Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens

Role: collaborator

NCT05997511Not ApplicableActive Not Recruiting

Leveraging Community Health Workers to Combat COVID-19 and Mental Health Misinformation in Haiti, Malawi, and Rwanda

Role: collaborator

NCT04777006Phase 4Active Not Recruiting

Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform

Role: collaborator

NCT03827811Unknown

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis

Role: collaborator

NCT03259269Completed

Expand New Drugs for TB [endTB]

Role: lead

NCT04258085Completed

Promoting Earlier Detection of Breast Cancer in Rwanda: Scaleup in the National Health Care System

Role: collaborator

NCT02964091Phase 4Completed

Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World

Role: lead

NCT03919682Not ApplicableCompleted

Promoting Early Detection of Breast Cancer in Rural Rwanda: Impact of Community Health Worker and Nurse Training

Role: collaborator

NCT03890211Not ApplicableUnknown

Trial of a Non Electric Infant Warmer for Prevention and Treatment of Hypothermia in Rwanda

Role: collaborator

NCT04283929Not ApplicableUnknown

Evaluation of Clinical Impacts and Costs of eHealth in Rwanda

Role: collaborator

NCT03031431Not ApplicableCompleted

Electricity-free Infant Warmer for Newborn Thermoregulation in Rwanda

Role: collaborator

NCT03106727Not ApplicableCompleted

Evaluating the Impact of a Community Health Worker Program in Neno, Malawi

Role: lead

NCT03888729Phase 4Unknown

Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)

Role: lead

NCT03665012Completed

The Pediatric Development Clinic Study

Role: lead

NCT02864433Completed

Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts

Role: collaborator